Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer

doi:10.4251/wjgo.v11.i1.17

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11729)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

578

WORD

370

HTML

5946

Figures (1-4)

294

Tables (1-1)

222

Sum=7410

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

600

Download

991

Sum=1591

Publishing Process of This Article

Item

Count

Browse

1050

Download

1678

Sum=2728

Jan 15, 2019 (publication date) through Nov 1, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Jan 15, 2019; 11(1): 17-27
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.17

Full Size Figure Download Figure

Figure 3 Evaluation of serum tumor markers before and after surgery. A: Disease-free survival curves according to perioperative changes in carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels; B: Effects of postoperative adjuvant chemotherapy on the prognostic impact of the perioperative levels of CEA and CA19-9. CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9.

Citation: Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer. World J Gastrointest Oncol 2019; 11(1): 17-27
URL: https://www.wjgnet.com/1948-5204/full/v11/i1/17.htm
DOI: https://dx.doi.org/10.4251/wjgo.v11.i1.17